How I became a slow traveler with MS: the medication decision that changed everything
For most of my adult life, long-term travel was a someday plan. Something I’d do when I had more money, more stability, fewer medical appointments stacked on the calendar.
Then I got rediagnosed, and someday started looking a lot less guaranteed.
This piece is about the specific decision that changed that. Not a mindset shift, not a motivational moment — a medication switch. Switching to twice-yearly infusions removed the single biggest logistical barrier between me and six months abroad, and this is the story of how I figured that out, fought my insurance company for months, and finally got on a plane.
It was published on Bezzy MS, a medically reviewed community platform by Healthline Media, and it’s the piece that explains the origin of The Status Go.
Key Takeaways:
After 15 years with relapsing-remitting MS, a rediagnosis of secondary progressive MS in 2020 made one thing clear: later was not an option for me.
Monthly infusions meant monthly trips home, daily pills meant complicated pharmacy relations, and that all made long-term travel structurally impossible. Securing a six-month medication supply required months of insurance calls, hold music, and follow-ups – the logistics nobody talks about when they tell you to just go travel.
Then, a switch to twice-yearly Ocrevus changed the math entirely.
The first trip after the switch: six months in Western Europe, six countries, one carry-on, and a nervous system that finally had enough runway to rest whenever I need it.
But slow travel wasn’t just a compromise for managing MS while exploring the world or vacationing. It turned out to be a better version of travel that can be available to absolutely anyone.
status quo → go 🧡
This post may contain affiliate links. I may earn a small commission at no extra cost to you, but I only recommend products I actually love, promise.